Funding sources The authors acknowledge the following institutions for their support: Biomedical Research Committee, The University of Nottingham, Nottingham, U.K., British Geological Survey, Nottingham, U.K., and Cegedim Strategic Data – Medical Research, U.K.
Epidemiology and health services research
Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004–10)
Article first published online: 31 OCT 2013
© 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 169, Issue 5, pages 1093–1099, November 2013
How to Cite
Musah, A., Gibson, J.E., Leonardi-Bee, J., Cave, M.R., Ander, E.L. and Bath-Hextall, F. (2013), Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004–10). British Journal of Dermatology, 169: 1093–1099. doi: 10.1111/bjd.12446
Conflicts of interest None declared.
- Issue published online: 31 OCT 2013
- Article first published online: 31 OCT 2013
- Accepted manuscript online: 24 MAY 2013 01:42AM EST
- Manuscript Accepted: 14 MAY 2013
- Biomedical Research Committee
Basal cell carcinoma (BCC) is one of the most common types of nonmelanoma skin cancer affecting the white population; however, little is known about how the incidence varies across the U.K.
To determine the variation in BCC throughout the U.K.
Data from 2004 to 2010 were obtained from The Health Improvement Network database. European and world age-standardized incidence rates (EASRs and WASRs, respectively) were obtained for country-level estimates and levels of socioeconomic deprivation, while strategic health-authority-level estimates were directly age and sex standardized to the U.K. standard population. Incidence-rate ratios were estimated using multivariable Poisson regression models.
The overall EASR and WASR of BCC in the U.K. were 98·6 per 100 000 person-years and 66·9 per 100 000 person-years, respectively. Regional-level incidence rates indicated a significant geographical variation in the distribution of BCC, which was more pronounced in the southern parts of the country. The South East Coast had the highest BCC rate followed by South Central, Wales and the South West. Incidence rates were substantially higher in the least deprived groups and we observed a trend of decreasing incidence with increasing levels of deprivation (P < 0·001). Finally, in terms of age groups, the largest annual increase was observed among those aged 30–49 years.
Basal cell carcinoma is an increasing health problem in the U.K.; the southern regions of the U.K. and those in the least deprived groups had a higher incidence of BCC. Our findings indicate an increased incidence of BCC for younger age groups below 49 years.